Sun Pharmaceutical informed the BSE on Thursday that its subsidiary Sun Pharma Laboratories has raised Rs 1,000 crore through non-convertible debentures.
"Sun Pharma Laboratories Limited, a wholly-owned subsidiary of the company, has raised, on Private Placement Basis, rupees one thousand crore only by allotment of 10,000 (ICRA) AAA/stable outlook rated unsecured redeemable non-convertible debentures of a face value of Rs. 10,00,000," Sun Pharma said in a BSE filing.
It said the debentures will be listed on BSE under two series with Series 1 debentures comprising 5,000 debentures amounting to rupees five hundred crore with a tenor of 24 months, and Series 2 debentures comprising 5,000 debentures amounting to rupees five hundred crores with a tenor of 39 months.
Sun Pharma stock was trading at Rs 794.10 on BSE, up 0.47 per cent at 12.30 pm.